A Telehealth Advance Care Planning Intervention
NCT05875805 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207
Last updated 2026-04-03
Summary
The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.
Conditions
- Myeloid Malignancy
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasm
- Myelofibrosis
Interventions
- BEHAVIORAL
-
Telehealth Serious Illness Care Program
The adapted telehealth Serious Illness Care Program is a multilevel intervention engaging the patient, caregiver, clinician, and system. It consists of tools, training, and system change. Tools include: 1) The Serious Illness Conversation Guide for clinicians; and 2) Education materials for patients on the importance of Serious Illness Conversations (Patient Preparation Pamphlet) and of the involvement of caregivers (Family Communication Guide).
- OTHER
-
Education Control
Education materials developed by the NCI on "Communication in Cancer Care (PDQ®) - Patient Version"
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Principal Investigators
-
Kah Poh Loh · University of Rochester
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-20
- Primary Completion
- 2027-09-30
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
NCT06697600 ·Status: RECRUITING ·Phase: NA
-
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
NCT00053014 ·Status: TERMINATED ·Phase: PHASE2
-
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
NCT05433090 ·Status: COMPLETED ·Phase: NA
-
Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
NCT00005801 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
NCT00002514 ·Status: COMPLETED ·Phase: PHASE3
-
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)
NCT00038805 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
NCT01235572 ·Status: COMPLETED ·Phase: PHASE2
-
COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT03595787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy
NCT02226497 ·Status: TERMINATED ·Phase: NA
-
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
NCT02975869 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00002805 ·Status: COMPLETED ·Phase: PHASE2
-
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
NCT07094750 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission
NCT00150878 ·Status: TERMINATED ·Phase: PHASE3
-
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
NCT00004056 ·Status: COMPLETED ·Phase: PHASE1
-
Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia
NCT03408210 ·Status: UNKNOWN ·Phase: NA
-
Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT00844441 ·Status: COMPLETED ·Phase: NA
-
A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
NCT03310918 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
NCT02842112 ·Status: COMPLETED
-
Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia
NCT00199095 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00558519 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
NCT01339910 ·Status: TERMINATED ·Phase: PHASE3
-
Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia
NCT02446964 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
NCT00002549 ·Status: UNKNOWN ·Phase: PHASE3
-
Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)
NCT02101983 ·Status: COMPLETED ·Phase: NA